Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/19/2003EP0888471B1 Method and device for making composite sheets
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0846169B1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES
03/19/2003EP0804467B1 Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen
03/19/2003EP0800344B1 Use of coniferyl aldehyde and alpha-hexyl cinnamic aldehyde against insects and arachnids
03/19/2003EP0783695B1 Cell tests and diagnostic kit for alzheimer's disease
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003EP0736107B1 Automatic genotype determination
03/19/2003EP0736093B1 ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB-2 PLAYS A ROLL
03/19/2003EP0722463B1 Methods and composition for the modulation of host immune response to allergens
03/19/2003EP0711350B1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid
03/19/2003EP0711348B1 Process for the efficient production of 7-adca via 3-(carboxyethylthio)propionyl-7-adca
03/19/2003EP0677104B1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
03/19/2003EP0670904B1 Vector for the expression of therapy-relevant genes
03/19/2003EP0667902B1 Cdr grafted humanised chimeric t-cell antibodies
03/19/2003EP0595935B1 Papillomavirus Vaccine
03/19/2003EP0556333B1 Avirulent salmonella microbes comprising a mutation in the cdt gene and uses therefor
03/19/2003CN1404528A Transgenic cells expressing glucosyltransferase nucleic acids
03/19/2003CN1404488A NOGO receptor-mediated blockade of axonal growth
03/19/2003CN1404485A Process of purification of hCG and recombinant hCG purified by that method
03/19/2003CN1404415A Microarray fabrication techniques and apparatus
03/19/2003CN1404401A G-CSF conjugates
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1403590A Identifying probe and method for nucleotide sequence and nucleic acid molecule of red tide phaeocystis globosa
03/19/2003CN1403577A Fusion protein of type IV collagenase resistant single chain antibody and Lidamycin agon protein
03/19/2003CN1403576A Streptomycete 2-nitropropane dioxyenase gene and its application
03/19/2003CN1403575A Cloning-free linear expression vector constituting method
03/19/2003CN1403574A Modified EB virus LMP1 coding sequence and its prepn and application
03/19/2003CN1403570A Nikemycin Z component engineering bacterium and its application
03/19/2003CN1403569A In vivo established strain of genetic recombined inteferon and its use
03/19/2003CN1403484A Prepn and application of transmembrane staphylococcus aureus toxin A fusion protein
03/19/2003CN1403482A Prepn of aldose reductase-resisting similar protein polyclonal antibody
03/19/2003CN1403481A Production process of neurotrophic factor
03/19/2003CN1403480A Human protein with function of suppressing cancer cell growth and its coding sequence
03/19/2003CN1403479A Human protein with function of suppressing cancer cell growth and its coding sequence
03/19/2003CN1403478A Human protein with function of suppressing cancer cell growth and its coding sequence
03/19/2003CN1403477A Human protein with function of promoting 3T3 cell conversion and its coding sequence
03/19/2003CN1403476A Human protein with function of promoting 3T3 cell conversion and its coding sequence
03/19/2003CN1403475A Human protein with cancer suppressing function and its coding sequence
03/19/2003CN1403155A Recombinant gamma-interferon for preventing and treating cow's recessive mammitis
03/19/2003CN1402967A Hybridization reaction-promoting ultrasonic method and equipment
03/19/2003CN1103374C Process for producing human serum albumin with recombinant DNA technology
03/19/2003CN1103373C Human serum albumin reformed gene, expression vector and its host
03/19/2003CN1103370C Recombination human immunodeficiency virus producing cell
03/19/2003CA2421618A1 Transgenic plants which produce isomalt
03/18/2003US6534695 Identification and characterization of a Dwarf and Late Flowering 2 phenotype (DLF2) in Arabidopsis
03/18/2003US6534644 Isolated polynucleotide of given sequence; use to control lepidopterans and create plants that are insect resistant
03/18/2003US6534643 Isolated nucleic acid of given sequence; useful for homology-dependent pairing of three DNA strands; use in cloning and gene mapping
03/18/2003US6534642 Isolated nucleic acid of given sequence encoding a protein; dysfunction of the human protein implicated in hyper/hypocalcemia, bone disorders, leukemia and cancer
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534640 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids
03/18/2003US6534638 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
03/18/2003US6534633 Polyspecific binding molecules and uses thereof
03/18/2003US6534632 Sialidase localized in plasma membrane DNA coding for the same
03/18/2003US6534630 Connective tissue growth factor-2
03/18/2003US6534629 Isolated protein inhibiting blood coagulation factor X; use in drugs
03/18/2003US6534628 Proteins comprising one or more mutations of surface-exposed amino acids, directing them to different binding partners; stabililty
03/18/2003US6534626 Chemokine variants
03/18/2003US6534523 Racemates, diastereoisomers and optical isomers of a compound of formula (I): synthesis, compositions and methods for the treatment of hepatitis C virus (HCV) infection and intermediates
03/18/2003US6534485 Novel human protein called Bone Marrow-Specific Protein (BMSP), and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein.
03/18/2003US6534484 Methods for encapsulating plasmids in lipid bilayers
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534482 Expression vectors for stimulating an immune response and methods of using the same
03/18/2003US6534477 Production and use of modified cystatins
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534315 Yeast transformation cassette
03/18/2003US6534314 Methods and compositions for transforming cells
03/18/2003US6534313 A recombinant vector comprising polynucleotide sequence whose overexpression results in a dwarf phenotype; cytochrome; insect resistance and darker-green foliage
03/18/2003US6534312 Vaccines comprising synthetic genes
03/18/2003US6534310 Suppression of proteolytic activity by dysfunctional protease formation
03/18/2003US6534309 Motor proteins and methods for their use
03/18/2003US6534308 Apparatus for selectively identifying, and individually targeting with energy beam, specific cells within mixed cell population to induce response in targeted cells
03/18/2003US6534302 22438, 23553, 25278, and 26212 novel human sulfatases
03/18/2003US6534301 Nucleotide sequences coding enzymatic polypeptide for use in treating cell proliferation and differentiation defects
03/18/2003US6534300 Methods for producing highly phosphorylated lysosomal hydrolases
03/18/2003US6534299 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects
03/18/2003US6534298 Nucleic acids encoding α-1,3 fucosyltransferases and expression systems for making and expressing them
03/18/2003US6534297 Recombinantly producing levodione reductase
03/18/2003US6534293 Conducting global polymerase chain reaction amplification which creates genome representation, then conducting ligation detection reaction process whose ligation products are captured by hybridization to support
03/18/2003US6534292 Generating random fragments of nucleic acid and assembling recombined nucleic acid molecule using template fragments which have non-extendable ends
03/18/2003US6534291 Compositions and methods for fumonisin detoxification
03/18/2003US6534290 Methods for production of growth-promoting proteins and peptides for kidney epithelial cells
03/18/2003US6534289 Recombinant nucleic acid encoding receptor having amino acid sequences of extracellular domain of G-protein coupled calcium receptor, seven-transmembrane and intracellular cytoplasmic tail domains of group I metabotropic glutamate receptor
03/18/2003US6534288 Precursor of human insulin or insulin analog consisting of optional fusion portion, B chain of human insulin linked by amino acid chain to A chain of human insulin, in which chains can be modified with activity being preserved
03/18/2003US6534287 Isolated and purified nucleic acid molecule comprising nucleotides which code for specified amino acid sequence
03/18/2003US6534286 Protein production in Aureobasidium pullulans
03/18/2003US6534285 Composition comprising predetermined polypeptide sequence of AIDS-associated retrovirus comprising at least one antigenic determinant that specifically binds complementary antibody
03/18/2003US6534284 Isolated polynucleotide selected from polynucleotide encoding polypeptide having specified amino acid sequence, and polynucleotide fully complementary to that polynucleotide
03/18/2003US6534276 Methods for detecting human tissue factor inhibitor
03/18/2003US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof
03/18/2003US6534274 Molecular torches
03/18/2003US6534271 Propagating ligands and receptors on surfaces; immobilize ligand on surface, mix with receptors, transfer bound receptor to second surface, join ligand to immbolized receptor, transfer ligand to first surface
03/18/2003US6534269 Pyrophosphorolysis activated polymerization (PAP): application to allele-specific amplification and nucleic acid sequence determination
03/18/2003US6534268 Isolated nucleic acid corresponding to specified nucleotide sequence that encodes human bone morphogenetic protein-7 promoter region
03/18/2003US6534267 Polynucleotides encoding activators of caspases
03/18/2003US6534265 Oryzacystatin-I protease inhibitor peptide comprising specified amino acid sequence; insecticides, viricides
03/18/2003US6534262 Separating nucleic acid molecules in mixture on basis of differences in molecular size by selectively adsorbing target molecules to magnetically responsive solid phase carrier such as paramagnetic microparticles
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534101 Enzymes mixture obtained from Penicillium funiculosum
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
1 ... 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 ... 4023